Polymyalgia rheumatica is not considered curable, but it is manageable with treatment. Most patients respond well to corticosteroids, which can significantly alleviate symptoms and reduce inflammation. While many people experience remission and may eventually taper off medication, some may have persistent symptoms and require long-term management. Regular follow-up with a healthcare provider is essential to monitor and adjust treatment as needed.
polymyalgia rheumatica
Polymyalgia rheumatica is a syndrome that causes pain and stiffness in the hips and shoulders of people over the age of 50.
Polymyalgia means "pain in many muscles". It is usually associated with the condition Polymyalgia rheumatica, a form of pain and stiffness that affects muscle groups throughout the body often simultaneously.
Women are afflicted twice as often as men.
If someone has polymyalgia rheumatica, they will more then likely endure stiffness in their neck, hips, and both shoulders. This stiffness will be worse in the morning and after long periods of inactivity. This stiffness will also be followed by limited range of motion in those joints.
PMR is an acronym for: polymyalgia rheumatica.
Depending on context, it could mean polymyalgia rheumatica or patient medical report.
Polymyalgia rheumatica is not classified as a form of arthritis, but it is an inflammatory condition that causes muscle pain and stiffness, particularly in the shoulders and hips. While it shares some symptoms with arthritis, such as joint discomfort and stiffness, it primarily affects the muscles rather than the joints themselves. Polymyalgia rheumatica is often associated with giant cell arteritis and can respond well to corticosteroid treatment.
Rarely does it affect people under 50 years old. The average age is 70.
No, polymyalgia rheumatica (PMR) is not contagious. It is an inflammatory condition that primarily affects older adults, characterized by muscle pain and stiffness. The exact cause of PMR is not fully understood, but it is believed to involve genetic and environmental factors rather than infectious agents. As such, it cannot be transmitted from one person to another.
The major characteristics are pain and stiffness, however patients are commonly so afflicted that their muscles atrophy from disuse.
Polymyalgia rheumatica has a prevalence of about 0.5% in individuals over the age of 50. It is more common in people of Northern European descent and in women compared to men. The prevalence increases with age, peaking around 70-80 years old.